NDC Product
Human Prescription DrugMyfembree NDC 72974-415
- Generic Name
- Relugolix, Estradiol Hemihydrate, And Norethindrone Acetate
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Marketing
- NDA
Active Listing
This profile provides standardized clinical and technical data for Relugolix, uniquely identified by the FDA Unique Ingredient Identifier (UNII) P76B05O5V6.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 737789-87-6 and the RxNorm Concept ID (RxCUI) 2472778. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
C29H27F2N7O5S AOMXMOCNKJTRQP-UHFFFAOYSA-N This section provides a complete list of nomenclature and identifier mappings for Relugolix. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
This unique ingredient identifier is listed as an ingredient or substance in the following products in the NDC directory: